Showing 1,741 - 1,760 results of 17,928 for search 'significant ((((((gap decrease) OR (step decrease))) OR (nn decrease))) OR (a decrease))', query time: 0.62s Refine Results
  1. 1741

    Cardiomyocyte apoptosis rate in the Sham group. by Qingqing Hao (5464070)

    Published 2024
    “…</p><p>Results</p><p>1) In comparison to the Sham group, the expression of LC3 and Beclin1 was significantly increased, and the expression of p62 protein was decreased in the heart tissues of rabbits in the HF group. …”
  2. 1742

    Cardiomyocyte apoptosis rate in the three groups. by Qingqing Hao (5464070)

    Published 2024
    “…</p><p>Results</p><p>1) In comparison to the Sham group, the expression of LC3 and Beclin1 was significantly increased, and the expression of p62 protein was decreased in the heart tissues of rabbits in the HF group. …”
  3. 1743

    Apoptosis ratio in three groups. by Qingqing Hao (5464070)

    Published 2024
    “…</p><p>Results</p><p>1) In comparison to the Sham group, the expression of LC3 and Beclin1 was significantly increased, and the expression of p62 protein was decreased in the heart tissues of rabbits in the HF group. …”
  4. 1744

    S1 File - by Qingqing Hao (5464070)

    Published 2024
    “…</p><p>Results</p><p>1) In comparison to the Sham group, the expression of LC3 and Beclin1 was significantly increased, and the expression of p62 protein was decreased in the heart tissues of rabbits in the HF group. …”
  5. 1745

    Cardiomyocyte apoptosis rate in the HF group. by Qingqing Hao (5464070)

    Published 2024
    “…</p><p>Results</p><p>1) In comparison to the Sham group, the expression of LC3 and Beclin1 was significantly increased, and the expression of p62 protein was decreased in the heart tissues of rabbits in the HF group. …”
  6. 1746
  7. 1747

    Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation by Huang-Ju Tu (630766)

    Published 2024
    “…Although the development of DYRK1A inhibitors has significantly advanced in recent years, the selectivity of these drugs remains a critical challenge, potentially impeding further progress. …”
  8. 1748
  9. 1749
  10. 1750
  11. 1751
  12. 1752
  13. 1753
  14. 1754
  15. 1755
  16. 1756
  17. 1757
  18. 1758
  19. 1759
  20. 1760

    S1 File - by Chantelle M. de Vet (16535257)

    Published 2024
    “…</p><p>Conclusions</p><p>A clear learning effect was observed by the significant decrease in variability of the difference in the score between the expert and trainees over time. …”